Allarity Therapeutics (ALLR) Tax Provisions (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Tax Provisions came in at -$377000.0 in Q3 2024, down 9325.0% on a QoQ basis from -$4000.0 in Q1 2024.
Allarity Therapeutics (ALLR) Tax Provisions (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Tax Provisions data on file, last reported at -$377000.0 in Q3 2024.
- Quarterly Tax Provisions changed N/A year-over-year to -$377000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$377000.0 (up 84.84% YoY) and the FY2024 annual result came in at -$381000.0, up 84.65% from the prior year.
- Tax Provisions slipped to -$377000.0 in Q3 2024, from -$4000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $50000.0 in Q3 2020 to a low of -$2.5 million in Q4 2023.
- A 5-year average of -$319307.7 and a median of $5000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions tumbled 30.0% — and 2022, when it sank 3818.18%.
- Tracing ALLR's Tax Provisions over 5 years: stood at $50000.0 in 2020, then fell by 30.0% to $35000.0 in 2021, then sank by 965.71% to -$303000.0 in 2022, then tumbled by 719.14% to -$2.5 million in 2023, then surged by 84.81% to -$377000.0 in 2024.
- The last three Tax Provisions figures came in at -$377000.0 (Q3 2024), -$4000.0 (Q1 2024), and -$2.5 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -377,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -2.48 Mn |
| Dec 31, 2022 | -303,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | -1.23 Mn |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 30,000.00 |
| Mar 31, 2021 | 33,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Sep 30, 2020 | 50,000.00 |